Virex Spray
NDC Package 83027-0156-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Virex (adenoviren nosode, asclepias tuberosa, calcarea arsenicica, camphora, coxsackie a2 nosode, coxsackie a3 nosode, coxsackie a4 nosode, coxsackie a5 nosode, coxsackie a7 nosode, coxsackie b1 nosode, coxsackie b3 nosode, coxsackie b4 nosode, coxsackie b5 nosode, cytomegalovirus nosode, echinacea purpurea, epstein-barr virus nosode, euphrasia officinalis, influenzinum, lac vaccinum, morbillinum, natrum muriaticum, phytolacca decandra, thuja occidentalis, trifolium pratense, variolinum) sprays is • Adults: 2 to 3 sprays orally, three times daily. This formulation utilizes a spray delivery system. Marketed by Nutritional Specialties, Inc., this product is identified by NDC 83027-0156.

Identification & Billing

NDC Package Code
83027-0156-1
Package Description
60 mL in 1 BOTTLE, SPRAY
Product Code
11-Digit Billing Format
83027015601

Clinical Specifications

Proprietary Name
Virex
Non-Proprietary Name
Adenoviren Nosode, Asclepias Tuberosa, Calcarea Arsenicica, Camphora, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A5 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B4 Nosode, Coxsackie B5 Nosode, Cytomegalovirus Nosode, Echinacea Purpurea, Epstein-barr Virus Nosode, Euphrasia Officinalis, Influenzinum, Lac Vaccinum, Morbillinum, Natrum Muriaticum, Phytolacca Decandra, Thuja Occidentalis, Trifolium Pratense, Variolinum
Substance Name
Asclepias Tuberosa Root; Calcium Arsenate; Camphor (natural); Cow Milk; Echinacea Purpurea Whole; Euphrasia Stricta; Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen; Human Coxsackievirus A; Human Coxsackievirus A2; Human Coxsackievirus A7; Human Coxsackievirus B; Human Coxsackievirus B1; Human Coxsackievirus B3; Human Coxsackievirus B5; Human Herpesvirus 4; Human Herpesvirus 5; Influenza A Virus A/thailand/8/2022 Ivr-237 (h3n2) Antigen (formaldehyde Inactivated); Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated); Influenza B Virus B/austria/1359417/2021 Bvr-26 Whole; Influenza B Virus B/phuket/3073/2013 Bvr-1b Whole; Measles Virus; Phytolacca Americana Root; Sodium Chloride; Thuja Occidentalis Leafy Twig; Trifolium Pratense Flower; Variola Virus
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
• Adults: 2 to 3 sprays orally, three times daily. Children under twelve one half adult dosage.• Do not take within 15 minutes of consuming food, beverage or brushing teeth.• Consult a physician for use in children under 12 years of age.

Regulatory & Marketing

Labeler Name
Nutritional Specialties, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
10-03-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83027-0156-1 identifies a specific commercial package of 60 ml in 1 bottle, spray of Virex, a human over the counter drug labeled by Nutritional Specialties, Inc.. This spray is formulated for oral use and contains asclepias tuberosa root; calcium arsenate; camphor (natural); cow milk; echinacea purpurea whole; euphrasia stricta; human adenovirus e serotype 4 strain cl-68578 antigen; human coxsackievirus a; human coxsackievirus a2; human coxsackievirus a7; human coxsackievirus b; human coxsackievirus b1; human coxsackievirus b3; human coxsackievirus b5; human herpesvirus 4; human herpesvirus 5; influenza a virus a/thailand/8/2022 ivr-237 (h3n2) antigen (formaldehyde inactivated); influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated); influenza b virus b/austria/1359417/2021 bvr-26 whole; influenza b virus b/phuket/3073/2013 bvr-1b whole; measles virus; phytolacca americana root; sodium chloride; thuja occidentalis leafy twig; trifolium pratense flower; variola virus as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nutritional Specialties, Inc. on October 03, 2025. The current certification is valid through December 31, 2026.

How is this Nutritional Specialties, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83027015601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
83027-0156-1
11-Digit CMS (5-4-2)
83027-0156-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.